Artizan Biosciences: Funding, Investors & Team (Sep 2026)
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.
Artizan Biosciences has raised $1.5M across 1 funding round on record, the most recent an undisclosed round of $1.5M announced in Nov 2025.
That round is below the $42M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Artizan Biosciences Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Artizan Biosciences Funding Rounds
Artizan Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Artizan Biosciences Funding Compared to Other Biotechnology Startups
Artizan Biosciences' latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Artizan Biosciences in Biotechnology and New York
Companies Similar to Artizan Biosciences
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and…
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific…
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
ThirdLaw Molecular pioneers revolutionary Spiroligomer™ molecules for safer, more targeted, effective disease…
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain…
Weike Bio is a gene therapy drug development company.
Twinpig Biolab researches and develops anticancer drugs.
Kunshi Biotechnology is a drug developer with an emphasis on solid tumor cells.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
Step Pharma is a biotechnology company.
Artizan Biosciences Funding FAQs
What does Artizan Biosciences do?
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.
How much funding has Artizan Biosciences raised?
Artizan Biosciences has raised $1.5M across 1 round on record. The most recent is an undisclosed round of $1.5M announced in Nov 2025.
When did Artizan Biosciences last raise funding?
Artizan Biosciences' most recent funding round on record is an undisclosed round of $1.5M, announced in Nov 2025.
Where is Artizan Biosciences headquartered?
Artizan Biosciences is based in New York, United States.
How many employees does Artizan Biosciences have?
Artizan Biosciences is in the 1-10 employee band.
How does Artizan Biosciences' funding compare to other Biotechnology startups?
Artizan Biosciences' latest round of $1.5M is below the $42M median round size for Biotechnology companies on FundedIQ across 20 tracked companies over the last two years.
About FundedIQ's Artizan Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Artizan Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.